Strict LDL Monitoring Helps Reduce Plaque Volume

colesterol ldl placasThe aim of this study was to explore the relationship between temporal changes in coronary plaque volume and the intensity of lipid lowering treatments using coronary computed tomography (CTA).

 

Coronary computed tomography has acceptable accuracy in terms of quantitative measurement on plaque volume, enough to identify changes in volume according to LDL levels.

 

This multicenter study included 467 patients undergoing multislice CT angiography over more than two years (mean 3.2 years), whose lab data were available within one month of both baseline and follow-up coronary CTA. Out of these patients, 147 were enrolled in the study, for they had visible plaque compromising 336 vessels.

 

Researchers compared patients reaching a cutoff value of 70 mg/dl LDL vs. those who did not. Patients below 70 mg/dl showed a significant reduction of plaque progression vs. those above 70 mg/dl (12.7 ± 38.2 mm3 vs. 44.2 ± 73.6 mm3, respectively; p=0.014).

 

In multivariable analyzis, the only factor influencing plaque progression was LDL cholesterol level.

 

Conclusion

Strict control of LDL levels significantly reduces plaque volume progression accordion to the non-invasive measurement with multislice CTA.

 

Original Title: Impact of Intensive LDL Cholesterol Lowering on Coronary Artery Atherosclerosis Progression A Serial CT Angiography Study.

Reference: Sanghoon Shin et al. J Am Coll Cardiol Img. 2016. Online First.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...